LumiThera Closes 2nd Tranche of Series C Financing

SEATTLE, Jan. 13, 2020 -- (Healthcare Sales & Marketing Network) -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has closed the 2nd tranche of... Devices, Ophthalmology, Venture Capital LumiThera, Valeda, Light Delivery System, photobiomodulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news